---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-26-002726"
form_type: "8-K"
ticker: "NRC"
cik: "0000070487"
company_name: "NRC HEALTH"
filed_at: "2026-02-03T23:59:59+00:00"
generated_at: "2026-05-16T05:28:04.383828+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# NRC Health Q4 2025 revenue $35.2M; TRCV up 8% YoY to $144.1M

## Summary
- Q4 GAAP net income $1.8M ($0.08 diluted EPS); adjusted net income $3.4M ($0.16 diluted EPS).
- Adjusted EBITDA $8.7M (25% of revenue); operating cash flow $7.2M, up 13% YoY.
- Full-year 2025 revenue $137.4M; GAAP net income $11.6M ($0.50 EPS); adjusted net income $20.7M ($0.93 EPS).
- TRCV of $144.1M grew 8% YoY and sequentially for the fifth consecutive quarter.

## SEC filing metadata
- accession: 0001437749-26-002726
- form_type: 8-K
- ticker: NRC
- cik: 0000070487
- company_name: NRC HEALTH
- filed_at: 2026-02-03T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/70487/000143774926002726/0001437749-26-002726-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/70487/000143774926002726/nrc20260202_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-26-002726
- JSON: https://secwatch.observer/filing/0001437749-26-002726.json
- Plain text: https://secwatch.observer/filing/0001437749-26-002726.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.